+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 578 Pages
  • July 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338926

Global Analgesics Market to Reach $59.2 Billion by 2026


Pain management continues to be one of the most sought-after treatment options for patients within the healthcare arena that underscores the critical significance of analgesics. Analgesics are drugs meant for pain control primarily. The drugs work on the CNS and peripheral nervous system for reducing or blocking pain sensitivity. There are also analgesics which work by preventing creation of pain mediating chemicals in the body. Widely used for treatment of mild to acute pain attributed to several medical conditions, injuries, surgeries and terminal disorders, analgesics have ruled the pain management domain for the past several decades. These medications have provided medical practitioners with an effective option to alleviate pain and help improve quality of life for patients. One of the important growth factors for the market for analgesics worldwide is the aging population. Significant incidence of severe pain disorders, treatment options that are effective, and favorable regulations are the key driving forces of the market. Further, increasing prevalence of chronic diseases has also fostered the use of pain management therapeutics. Increasing innovation in the area, owing to increased research investment by drug development companies, for advancing combination of compounds for developing new and more effective analgesics with enhanced efficacy as well as fewer side effects, is another prominent factor contributing towards market growth.

Amid the COVID-19 crisis, the global market for Analgesics estimated at US$48.8 Billion in the year 2022, is projected to reach a revised size of US$59.2 Billion by 2026, growing at a CAGR of 4.7% over the analysis period. Prescription, one of the segments analyzed in the report, is projected to grow at a 4.4% CAGR to reach US$37.7 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the OTC segment is readjusted to a revised 5.1% CAGR for the next 7-year period. This segment currently accounts for a 38.2% share of the global Analgesics market.

The U.S. Market is Estimated at $15.9 Billion in 2022, While China is Forecast to Reach $8.2 Billion by 2026


The Analgesics market in the U.S. is estimated at US$15.9 Billion in the year 2022. The country currently accounts for a 32.76% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$8.2 Billion in the year 2026 trailing a CAGR of 6.5% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR while Rest of European market (as defined in the study) will reach US$8.8 Billion by the close of the analysis period.

Growth in these markets are benefiting from increasing incidence of diseases like cancer, arthritis, CVD, and also other acute and chronic diseases which causes severe pain. Cancer pain, neuropathic pain, post-operative pain, and lower back pain represent the important market segments. Increasing incidence of cancer globally is poised to be a key driving force for market growth. Further, increasing prevalence of chronic diseases has also fostered the use of pain management therapeutics. Increasing innovation in the area, owing to increased research investment by drug development companies, for advancing combination of compounds for developing new and more effective analgesics with enhanced efficacy as well as fewer side effects, is another prominent factor contributing towards market growth.

Opioids Segment to Reach $18.4 Billion by 2026


Opioid analgesic drugs represent the gold standard in pain relieving treatment of critically ill patients across disease segments, including COVID-19. Fentanyl, morphine, and hydromorphone are among the most commonly used IV opioid analgesic drugs in the ICU settings for COVID as well as non-COVID patients. Global Opioids segment is estimated at US$15.9 Billion in 2022, and is projected to reach US$18.4 Billion by 2026 reflecting a compounded annual growth rate of 3.7% over the analysis period. United States constitutes the largest regional market for Opioids segment, accounting for 29.9% of the global sales. China is poised to register the fastest compounded annual growth rate of 5.2% over the analysis period, to reach US$2.6 Billion by 2026.

Select Competitors (Total 146 Featured):

  • Amneal Pharmaceuticals Inc
  • Apotex Inc
  • AstraZeneca Plc
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Limited
  • Eli Lilly and Company
  • Endo International plc
  • F. Hoffmann-La Roche AG
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Iroko Pharmaceuticals, LLC
  • Johnson & Johnson
  • Lupin Limited
  • Novartis AG
  • Reckitt Benckiser Group plc
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd

What`s New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to the digital archives
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Analgesics

What is the estimated value of the Global Market for Analgesics?

The Global Market for Analgesics was estimated to be valued at $48.8 Billion in 2022.

What is the growth rate of the Global Market for Analgesics?

The growth rate of the Global Market for Analgesics is 4.9%, with an estimated value of $59.2 Billion by 2026.

What is the forecasted size of the Global Market for Analgesics?

The Global Market for Analgesics is estimated to be worth $59.2 Billion by 2026.

Who are the key companies in the Global Market for Analgesics?

Key companies in the Global Market for Analgesics include Amneal Pharmaceuticals Inc, Apotex Inc, AstraZeneca Plc, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Cipla Limited, Eli Lilly and Company and F. Hoffmann.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Analgesics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • A Prelude to Analgesics
  • Analgesics: Perfect Therapeutic Options to Solve Mild to Crippling Pain
  • Key Segments
  • Opioid Analgesics
  • Non-Opioid Analgesics
  • NSAIDs
  • Topical NSAIDs
  • Others
  • Acetaminophen
  • Adjuvant Analgesics
  • Impact of COVID-19 on Analgesics
  • NSAIDs
  • NSAIDs Tend to Decrease Effectiveness of COVID-19 Vaccines, States a Yale University Study
  • Opioid
  • Acetaminophen
  • Global Analgesics Market to Witness Rapid Growth
  • Drugs Indicated for Pain Management
  • The US and Europe Represent the Largest Regions, Asia-Pacific to Witness fastest Growth
  • Non-Opioids: Fastest Growing Category
  • Competition
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Aging Population & Increasing Burden of Chronic Diseases Spurs
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Rising Diabetes Prevalence Presents Opportunity for Cell Surface Markers: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
  • Growing Incidence of Cancer and the Associated Pain to Drive the Analgesics Market
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
  • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
  • Advancements in Design and Delivery of Analgesic Drugs
  • Development of Safer Opioids with More Safer Profiles
  • Drug Pipeline with Efficacious Drugs
  • OTC Analgesics Market to Witness Fastest Growth
  • Topical Analgesics Market Holds Significant Share
  • Combination Therapies Gain Prominence
  • A Few Novel Analgesic Products under Development
  • E-commerce Platforms Strengthen Pharmaceutical Distribution in Crisis Period
  • Neuropathic Pain Management: Market with High Potential
  • Migraine Market: A Core Vertical in CNS Pain Management
  • Migraine Care: Select Patent Expiries (2013-2015)
  • Reyvow, Eli Lilly’s Novel Migraine Drug with the Potential to Lead the Global Migraine Medications Market
  • Three New Migraine Drugs Obtain FDA Approval
  • Eli Lilly’s Emgality Receives FDA Approval
  • Increasing Cases of Peripheral Nerve Injuries Drive the Analgesics Market
4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS
UNITED STATES
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
CANADA
JAPAN
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
CHINA
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
EUROPE
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
FRANCE
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
GERMANY
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
ITALY
UNITED KINGDOM
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
AUSTRALIA
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
INDIA
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Analgesics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
IV. COMPETITION
  • Total Companies Profiled: 146

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Amneal Pharmaceuticals Inc
  • Apotex Inc
  • AstraZeneca Plc
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Limited
  • Eli Lilly and Company
  • Endo International plc
  • F. Hoffmann-La Roche AG
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Iroko Pharmaceuticals, LLC
  • Johnson & Johnson
  • Lupin Limited
  • Novartis AG
  • Reckitt Benckiser Group plc
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd